TriLogic Pharma Chief Scientific Officer to speak at Pharmaceutical Risk and Research Europe.
January 10, 2011

TriLogic Pharma announced that Chief Scientific Officer Hemant H. Alur, PhD, MBA has been invited to speak at the Pharmaceutical Risk and Research Europe Conference in London on March 24th.
Dr. Alur will present TriLogic Pharma’s novel drug delivery platform, TRI-726.
Pharmaceutical Research and Risk Europe focuses on finding potential solutions for the major challenges faced by the pharmaceutical industry. Key areas addressed at the conference include the potential for drug redevelopment and reformulation, process development, optimization, risk assessment and new strategies to develop R&D pipelines.

About Pharmaceutical Research and Risk Europe: